The company maintains a healthy financial position with a 2.10 current ratio and a conservative debt-to-equity ratio of 0.47 as of 2026Q2.
| Metric | TTM | Oct'25 | Oct'24 | Oct'23 | Oct'22 | Oct'21 | Oct'20 | Oct'19 | Oct'18 | Oct'17 | Oct'16 | Oct'15 | Oct'14 | Oct'13 | Oct'12 | Oct'11 | Oct'10 | Oct'09 | Oct'08 | Oct'07 | Oct'06 | Oct'05 | Oct'04 | Oct'03 | Oct'02 | Oct'01 | Oct'00 | Oct'99 | Oct'98 |
|---|
| Total Current Assets | 4.76B | 4.59B | 3.96B | 4.19B | 3.78B | 3.8B | 3.42B | 3.19B | 3.85B | 4.17B | 3.63B | 3.69B | 5.51B | 4.98B | 4.63B | 5.57B | 6.17B | 3.96B | 3.18B | 3.67B | 3.96B | 4.45B | 4.66B | 3.89B | 4.88B | 4.8B | 5.14B | 3.54B | 3.08B |
| Cash & Short-Term Investments | 1.81B | 1.79B | 1.33B | 1.59B | 1.05B | 1.57B | 1.44B | 1.38B | 2.25B | 2.68B | 2.29B | 2B | 2.22B | 2.67B | 2.35B | 3.53B | 2.65B | 2.49B | 1.43B | 1.83B | 2.26B | 2.25B | 2.31B | 1.61B | 1.84B | 1.17B | 996M | 0 | 0 |
| Cash Only | 1.81B | 1.79B | 1.33B | 1.59B | 1.05B | 1.48B | 1.44B | 1.38B | 2.25B | 2.68B | 2.29B | 2B | 2.22B | 2.67B | 2.35B | 3.53B | 2.65B | 2.48B | 1.41B | 1.83B | 2.26B | 2.23B | 2.31B | 1.61B | 1.84B | 1.17B | 996M | 0 | 0 |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 91M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 14M | 24M | 0 | 0 | 25M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 1.5B | 1.49B | 1.32B | 1.29B | 1.41B | 1.17B | 1.04B | 930M | 776M | 724M | 631M | 606M | 626M | 899M | 923M | 860M | 869M | 595M | 770M | 735M | 692M | 678M | 788M | 1.09B | 1.12B | 977M | 1.94B | 1.64B | 1.22B |
| Days Sales Outstanding | 74.29 | 78.12 | 74.23 | 68.96 | 74.89 | 67.7 | 70.96 | 65.75 | 57.64 | 59.09 | 54.81 | 54.78 | 56.45 | 84.27 | 49.12 | 47.45 | 58.26 | 48.47 | 48.68 | 49.5 | 50.79 | 48.16 | 40.05 | 88.72 | 67.96 | 42.47 | 75.57 | 87.38 | 55.77 |
| Inventory | 1.09B | 1.02B | 991M | 1.03B | 1.04B | 830M | 720M | 679M | 638M | 575M | 533M | 541M | 574M | 1.07B | 1.01B | 898M | 716M | 552M | 646M | 643M | 627M | 612M | 809M | 995M | 1.18B | 1.49B | 1.85B | 1.5B | 1.49B |
| Days Inventory Outstanding | 112.4 | 113.2 | 121.58 | 111.73 | 121.2 | 104.03 | 105.04 | 105.1 | 104.57 | 101.73 | 97.03 | 98.88 | 101.11 | 195.82 | 113.74 | 106.21 | 103.95 | 92.04 | 91.46 | 95.75 | 98.86 | 85.36 | 72.77 | 5.95K | 116.99 | 105.35 | 147.48 | 150.85 | 134.33 |
| Other Current Assets | 369M | 293M | 315M | 274M | 282M | 222M | 216M | 198M | 187M | 192M | 182M | 536M | 2.09B | 343M | 341M | 284M | 1.94B | 321M | 337M | 467M | 377M | 906M | 751M | 201M | 733M | 1.16B | 352M | 404M | 375M |
| Total Non-Current Assets | 8.3B | 8.13B | 7.89B | 6.58B | 6.75B | 6.91B | 6.21B | 6.26B | 4.69B | 4.26B | 4.16B | 3.79B | 5.31B | 5.7B | 5.91B | 3.49B | 3.53B | 3.65B | 3.83B | 3.88B | 3.41B | 2.3B | 2.48B | 2.41B | 3.32B | 3.19B | 3.19B | 1.91B | 1.91B |
| Property, Plant & Equipment | 2.1B | 2.02B | 1.96B | 1.42B | 1.1B | 945M | 845M | 850M | 822M | 757M | 639M | 604M | 631M | 1.13B | 1.16B | 1.01B | 980M | 845M | 824M | 801M | 775M | 873M | 1.26B | 1.45B | 1.58B | 1.85B | 1.74B | 1.39B | 1.48B |
| Fixed Asset Turnover | 3.54x | 3.43x | 3.33x | 4.80x | 6.23x | 6.69x | 6.32x | 6.07x | 5.98x | 5.91x | 6.58x | 6.69x | 6.42x | 3.43x | 5.89x | 6.58x | 5.56x | 5.30x | 7.01x | 6.77x | 6.42x | 5.89x | 5.71x | 3.09x | 3.81x | 4.54x | 5.38x | 4.92x | 5.37x |
| Goodwill | 4.48B | 4.47B | 4.47B | 3.96B | 3.95B | 3.98B | 3.6B | 3.59B | 2.97B | 2.61B | 2.52B | 2.37B | 2.51B | 3.05B | 3.02B | 1.57B | 1.46B | 655M | 646M | 736M | 385M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 407M | 445M | 547M | 475M | 821M | 981M | 831M | 1.11B | 491M | 361M | 408M | 445M | 649M | 916M | 1.09B | 429M | 494M | 167M | 228M | 0 | 83M | 362M | 443M | 402M | 685M | 1.07B | 557M | 0 | 0 |
| Long-Term Investments | 539M | 133M | 175M | 164M | 195M | 185M | 158M | 102M | 68M | 138M | 135M | 86M | 96M | 139M | 109M | 117M | 142M | 163M | 206M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 1.18B | 1.06B | 297M | 554M | 686M | 820M | 776M | 611M | 339M | 394M | 460M | 292M | 1.42B | 467M | 523M | 369M | 455M | 1.82B | 1.92B | 2.35B | 2.17B | 1.07B | 780M | 532M | 424M | 269M | 893M | 519M | 431M |
| Total Assets | 13.06B | 12.73B | 11.85B | 10.76B | 10.53B | 10.71B | 9.63B | 9.45B | 8.54B | 8.43B | 7.79B | 7.48B | 10.81B | 10.69B | 10.54B | 9.06B | 9.7B | 7.61B | 7.01B | 7.55B | 7.37B | 6.75B | 7.14B | 6.3B | 8.2B | 7.99B | 8.33B | 5.44B | 4.99B |
| Asset Turnover | 0.57x | 0.55x | 0.55x | 0.63x | 0.65x | 0.59x | 0.55x | 0.55x | 0.58x | 0.53x | 0.54x | 0.54x | 0.37x | 0.36x | 0.65x | 0.73x | 0.56x | 0.59x | 0.82x | 0.72x | 0.67x | 0.76x | 1.01x | 0.71x | 0.73x | 1.05x | 1.12x | 1.25x | 1.59x |
| Asset Growth % | 33.63% | 7.44% | 10.06% | 2.19% | -1.62% | 11.2% | 1.85% | 10.67% | 1.36% | 8.11% | 4.21% | -30.85% | 1.21% | 1.42% | 16.33% | -6.59% | 27.38% | 8.63% | -7.24% | 2.51% | 9.15% | -5.5% | 13.45% | -23.24% | 2.72% | -4.13% | 53.01% | 9.16% | - |
| Total Current Liabilities | 2.27B | 2.35B | 1.9B | 1.6B | 1.86B | 1.71B | 1.47B | 2.08B | 1.17B | 1.26B | 945M | 976M | 1.69B | 1.6B | 1.89B | 1.84B | 3.08B | 1.12B | 1.33B | 1.66B | 1.54B | 1.94B | 1.77B | 1.91B | 2.18B | 2B | 2.66B | 1.68B | 1.6B |
| Accounts Payable | 615M | 570M | 540M | 418M | 580M | 446M | 354M | 354M | 340M | 305M | 257M | 279M | 302M | 432M | 461M | 472M | 499M | 307M | 308M | 323M | 378M | 323M | 306M | 441M | 305M | 392M | 857M | 510M | 435M |
| Days Payables Outstanding | 62.2 | 62.95 | 66.25 | 45.3 | 67.72 | 55.9 | 51.64 | 54.8 | 55.73 | 53.96 | 46.79 | 50.99 | 53.2 | 79.36 | 51.71 | 55.83 | 72.45 | 51.19 | 43.61 | 48.1 | 59.6 | 45.05 | 27.52 | 2.64K | 30.14 | 27.7 | 68.21 | 51.32 | 39.35 |
| Short-Term Debt | 304M | 304M | 45M | 0 | 36M | 0 | 75M | 616M | 0 | 210M | 0 | 0 | 0 | 0 | 250M | 253M | 1.5B | 1M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6M | 110M | 0 | 0 |
| Deferred Revenue (Current) | 2.59B | 624M | 544M | 505M | 461M | 441M | 386M | 336M | 324M | 291M | 269M | 258M | 260M | 439M | 420M | 389M | 358M | 285M | 280M | 249M | 225M | 205M | 227M | 262M | 244M | 279M | 322M | 241M | 0 |
| Other Current Liabilities | 298M | 443M | 326M | 371M | 455M | 493M | 367M | 334M | 304M | 276M | 235M | 221M | 851M | 401M | 387M | 424M | 0 | 0 | 0 | 954M | 804M | 1.25B | 1.03B | 892M | 1.06B | 570M | 679M | 930M | 1.16B |
| Current Ratio | 2.10x | 1.96x | 2.09x | 2.61x | 2.03x | 2.22x | 2.33x | 1.53x | 3.29x | 3.30x | 3.85x | 3.78x | 3.26x | 3.11x | 2.45x | 3.03x | 2.00x | 3.53x | 2.39x | 2.21x | 2.57x | 2.30x | 2.63x | 2.04x | 2.24x | 2.40x | 1.93x | 2.10x | 1.92x |
| Quick Ratio | 1.62x | 1.52x | 1.57x | 1.97x | 1.47x | 1.74x | 1.84x | 1.21x | 2.74x | 2.85x | 3.28x | 3.22x | 2.92x | 2.45x | 1.91x | 2.54x | 1.77x | 3.04x | 1.91x | 1.82x | 2.17x | 1.98x | 2.17x | 1.52x | 1.69x | 1.65x | 1.23x | 1.21x | 0.99x |
| Cash Conversion Cycle | 124.49 | 128.37 | 129.57 | 135.39 | 128.36 | 115.83 | 124.36 | 116.05 | 106.48 | 106.86 | 105.06 | 102.66 | 104.36 | 200.73 | 111.15 | 97.84 | 89.77 | 89.32 | 96.53 | 97.15 | 90.05 | 88.46 | 85.3 | 3.4K | 154.81 | 120.12 | 154.84 | 186.9 | 150.75 |
| Total Non-Current Liabilities | 3.67B | 3.64B | 4.05B | 3.31B | 3.37B | 3.61B | 3.29B | 2.62B | 2.8B | 2.33B | 2.6B | 2.33B | 3.82B | 3.79B | 3.46B | 2.9B | 3.38B | 3.98B | 3.12B | 2.66B | 2.17B | 734M | 1.8B | 1.57B | 1.4B | 325M | 402M | 381M | 366M |
| Long-Term Debt | 3.05B | 3.05B | 3.35B | 2.73B | 2.73B | 2.73B | 2.28B | 1.79B | 1.8B | 1.8B | 1.9B | 1.66B | 1.66B | 2.7B | 2.11B | 1.93B | 2.19B | 2.9B | 2.13B | 2.09B | 1.5B | 0 | 1.15B | 1.15B | 1.15B | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 142M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 182M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 623M | 589M | 566M | 580M | 633M | 879M | 1B | 833M | 1B | 527M | 699M | 678M | 2.16B | 1.1B | 1.35B | 972M | 1.19B | 1.07B | 993M | 570M | 490M | 734M | 653M | 417M | 245M | 325M | 402M | 381M | 366M |
| Total Liabilities | 5.94B | 5.99B | 5.95B | 4.92B | 5.23B | 5.32B | 4.75B | 4.7B | 3.97B | 3.59B | 3.55B | 3.31B | 5.51B | 5.4B | 5.35B | 4.74B | 6.46B | 5.1B | 4.45B | 4.32B | 3.71B | 2.67B | 3.58B | 3.47B | 3.58B | 2.33B | 3.06B | 2.06B | 1.97B |
| Total Debt | 3.35B | 3.35B | 3.57B | 2.73B | 2.77B | 2.73B | 2.36B | 2.41B | 1.8B | 2.01B | 1.9B | 1.66B | 1.66B | 2.7B | 2.36B | 2.19B | 3.69B | 2.9B | 2.13B | 2.09B | 1.5B | 0 | 1.15B | 1.15B | 1.15B | 6M | 110M | 0 | 0 |
| Net Debt | 1.55B | 1.56B | 2.25B | 1.15B | 1.72B | 1.25B | 918M | 1.02B | -448M | -667M | -385M | -348M | -555M | 24M | 11M | -1.34B | 1.04B | 426M | 720M | 261M | -762M | -2.23B | -1.17B | -457M | -694M | -1.16B | -886M | 0 | 0 |
| Debt / Equity | 0.47x | 0.50x | 0.61x | 0.47x | 0.52x | 0.51x | 0.48x | 0.51x | 0.39x | 0.42x | 0.45x | 0.40x | 0.31x | 0.51x | 0.46x | 0.51x | 1.14x | 1.16x | 0.83x | 0.65x | 0.41x | - | 0.32x | 0.41x | 0.25x | 0.00x | 0.02x | - | - |
| Debt / EBITDA | 1.90x | 1.90x | 2.05x | 1.69x | 1.43x | 1.64x | 2.04x | 2.04x | 1.61x | 1.91x | 2.21x | 2.14x | 2.07x | 3.56x | 1.66x | 1.65x | 4.82x | 13.90x | 2.13x | 2.69x | 2.37x | - | 1.90x | - | - | - | 0.08x | - | - |
| Net Debt / EBITDA | 0.88x | 0.89x | 1.29x | 0.71x | 0.89x | 0.75x | 0.80x | 0.87x | -0.40x | -0.63x | -0.45x | -0.45x | -0.69x | 0.03x | 0.01x | -1.01x | 1.36x | 2.04x | 0.72x | 0.34x | -1.20x | -6.17x | -1.93x | - | - | - | -0.64x | - | - |
| Interest Coverage | 15.72x | 13.81x | 16.84x | 15.09x | 18.90x | 17.79x | 11.79x | 13.42x | 13.61x | 11.16x | 8.56x | 8.27x | 3.08x | 3.61x | 11.33x | 13.00x | 8.21x | 1.08x | 7.63x | 6.42x | - | - | - | -3.64x | - | - | - | - | 9.61x |
| Total Equity | 7.12B | 6.74B | 5.9B | 5.84B | 5.3B | 5.39B | 4.87B | 4.75B | 4.57B | 4.83B | 4.25B | 4.17B | 5.3B | 5.29B | 5.18B | 4.32B | 3.24B | 2.51B | 2.56B | 3.23B | 3.66B | 4.08B | 3.57B | 2.82B | 4.63B | 5.66B | 5.26B | 3.38B | 3.02B |
| Equity Growth % | 52.89% | 14.29% | 0.91% | 10.18% | -1.56% | 10.59% | 2.63% | 3.87% | -5.46% | 13.87% | 1.82% | -21.38% | 0.28% | 2.01% | 20.13% | 33.37% | 29.13% | -2.07% | -20.87% | -11.62% | -10.34% | 14.35% | 26.38% | -38.97% | -18.24% | 7.48% | 55.68% | 11.91% | - |
| Book Value per Share | 25.08 | 23.74 | 20.27 | 19.75 | 17.68 | 17.55 | 15.62 | 14.93 | 14.06 | 14.83 | 12.91 | 12.45 | 15.69 | 15.33 | 14.69 | 12.16 | 9.17 | 7.24 | 6.90 | 7.97 | 8.30 | 8.16 | 7.28 | 5.97 | 9.95 | 12.36 | 11.57 | 7.39 | 6.58 |
| Total Shareholders' Equity | 7.12B | 6.74B | 5.9B | 5.84B | 5.3B | 5.39B | 4.87B | 4.75B | 4.57B | 4.83B | 4.24B | 4.16B | 5.3B | 5.29B | 5.18B | 4.31B | 3.23B | 2.51B | 2.56B | 3.23B | 3.65B | 4.08B | 3.57B | 2.82B | 4.63B | 5.66B | 5.26B | 3.38B | 3.02B |
| Common Stock | 3M | 3M | 3M | 3M | 3M | 3M | 3M | 3M | 3M | 3M | 6M | 6M | 6M | 6M | 6M | 6M | 6M | 6M | 6M | 6M | 5M | 5M | 5M | 5M | 5M | 5M | 5M | 4M | 0 |
| Retained Earnings | 1.69B | 1.39B | 750M | 782M | 324M | 348M | 81M | -18M | -336M | -126M | 6.09B | 5.58B | 6.47B | 6.07B | 5.5B | 4.46B | 3.44B | 2.76B | 2.79B | 2.17B | 1.53B | -1.46B | -1.81B | -2.16B | -101M | 931M | 757M | 0 | 0 |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -10.51B | -10.07B | -9.81B | -9.61B | -8.71B | -8.54B | -8.04B | -7.63B | -7.47B | -6.47B | -4.53B | -290M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -202M | -226M | -305M | -327M | -347M | -282M | -522M | -514M | -408M | -352M | -503M | -401M | -334M | 91M | -111M | 116M | -88M | -185M | -178M | 408M | 29M | -49M | 159M | -6M | -149M | 0 | -5M | 0 | 3.02B |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4M | 4M | 3M | 3M | 3M | 3M | 3M | 8M | 8M | 0 | 0 | 0 | 11M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Geopolitical and cyclical exposure
According to recent balance sheet filings, Agilent has expanded its total asset base from $10.9 billion in 2024Q1 to $13.1 billion by 2026Q2, reflecting a consistent trajectory of capital investment that aligns with the company's broader strategy of scaling its integrated laboratory workflow and service infrastructure.
The steady growth in total assets suggests that management is successfully deploying capital to support long-term operational capacity. This expansion appears to be funded by a combination of retained earnings and disciplined debt management, indicating a strengthening financial foundation that supports the company's competitive positioning.
Based on reported financial statements, Agilent maintains a conservative debt-to-equity ratio of 0.47 as of 2026Q2, which remains well within historical norms and provides the company with significant financial flexibility to navigate potential macroeconomic headwinds or pursue strategic tuck-in acquisitions without overextending its balance sheet.
The current debt load of $3.4 billion appears manageable given the company's consistent cash generation and strong market position. This low leverage profile suggests that Agilent is well-positioned to withstand periods of industrial contraction, as the interest burden remains relatively light compared to its operational cash flow.
As reported in quarterly disclosures, Agilent’s current ratio of 2.10 in 2026Q2 demonstrates a healthy liquidity position, providing a substantial buffer against short-term operational shocks and ensuring the company can meet its immediate obligations while continuing to fund ongoing research and development initiatives across its segments.
The consistent maintenance of a current ratio above 2.0 indicates a prudent approach to working capital management. This liquidity cushion is particularly important given the inherent lumpiness of large-scale instrument sales and the potential for supply chain disruptions to impact inventory turnover cycles.
Data from recent balance sheets shows that Agilent’s retained earnings have grown to $1.7 billion in 2026Q2 from $1.1 billion in 2024Q2, signaling that the company is effectively reinvesting its profits into the business to drive long-term value creation rather than relying solely on external financing.
The steady accumulation of retained earnings suggests a high-quality equity base that is increasingly self-sustaining. This trend implies that the company's internal capital allocation is generating sufficient returns to bolster its net worth, which should provide comfort to investors regarding the durability of the business model.
Based on the provided financial data, goodwill remains a significant component of the balance sheet at $4.5 billion as of 2026Q2, representing a substantial portion of total assets that requires ongoing vigilance regarding potential impairment risks should the performance of acquired diagnostic and genomics businesses falter.
While the current valuation of these intangible assets appears supported by segment performance, the concentration of goodwill warrants further investigation into the underlying assumptions of recent acquisitions. Investors should monitor whether these assets continue to deliver the expected synergies, as any significant write-down could materially impact the company's reported equity.
Quick answers to the most common questions about buying A stock.
As of 2025, Agilent Technologies, Inc. (A) had total assets of $12.73B including $4.59B in current assets.
Agilent Technologies, Inc. (A) carries total debt of $3.35B, offset by $1.79B in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
Agilent Technologies, Inc. (A) has total shareholders' equity (book value) of $6.74B ($23.74 book value per share). Book value represents the net worth of the company belonging to common stock holders.
Agilent Technologies, Inc. (A) reported a current ratio of 1.96x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.